and the National Science Foundation. This article also includes an updated assessment of the proportion of biodefense funding provided for programs that address multiple scientific, public health, healthcare, national security, and international security issues in addition to biodefense. The FY2014 federal budget for civilian biodefense totals $6.69 billion.
T his article analyzes federal government funding for civilian biodefense from fiscal year (FY) 2001 through the proposed budget for FY2014. This analysis uses information from FY2014 budget materials, as well as figures from the 9 previous articles in this series (formerly titled ''Billions for Biodefense''). [1] [2] [3] [4] [5] [6] [7] [8] [9] Based on this year's analysis of the FY2014 presidential budget, biodefense funding for FY2014 would receive an increase when compared to current estimates of FY2013 funding levels. The total proposed FY2014 budget for civilian biodefense programs is $6.69 billion (Table 1, Figure 1 ).
A majority of the programs included from the FY2014 biodefense budget have both biodefense and nonbiodefense goals and applications. For some of these programs, biodefense is a secondary goal. These programs are intended to address a range of scientific, public health, healthcare, national security, and international security issues in addition to biodefense. Programs with both biodefense and nonbiodefense goals and applications include those that fund basic scientific research in infectious disease pathogenesis and immunology, programs to improve planning and operations related to public health preparedness, and programs to improve preparedness and response for a range of other disasters. The Department of Homeland Security (DHS) was created in FY2003.
b DHS was unable to provide complete data; accordingly, some items are missing. See Table 4 . This analysis shows that approximately 88% ($5.86 billion) of the $6.69 billion budgeted in FY2014 for programs with biodefense in the mission or title is intended not only to improve biodefense, but also to address a range of scientific, public health, healthcare, agriculture, national security, and international security issues. In contrast, 12% ($853 million) of the FY2014 biodefense budget would go to programs that have objectives solely related to biodefense (Table 2, Figure 2 ). In recent years, approximately 10% of proposed funding is for solely biodefense-related projects. However, this year's proposed budget includes funds for Project BioShield, which had previously been funded by large appropriations in FY2004, FY2005, and FY2009. This proposed funding increases the estimated proportion of funds for solely biodefense-related programs in FY2014. Over the course of the 14 fiscal years in this analysis, including proposed funding for FY2014, $64.93 billion of the $78.83 billion total in biodefense funding has been dedicated to programs with both biodefense and nonbiodefense goals and applications, while only $13.89 billion has gone to programs with objectives solely related to biodefense (Table 2, Figure 2 ).
Funding Trends
Based on analyses from previous biodefense funding articles and updated numbers for this year's article, it appears that the overall proposed FY2014 biodefense budget would be increased compared to estimated funding levels for FY2013. [1] [2] [3] [4] [5] [6] [7] [8] [9] Proposed funding for construction of the National Bio and Agro-Defense Facility (NBAF) is the main contributor to the overall funding increase shown in this analysis. The facility will support research on foreign animal, emerging, and zoonotic diseases that threaten animal health, agriculture, and public health. Funding increases are proposed for biodefense programing in the Department of Health and Human Services (HHS), the Department of Defense (DoD), the Department of Homeland Security (DHS), the Department of Agriculture (USDA), and the Department of Commerce. Additionally, as with recent past analyses, a number of biodefense programs have been combined with other line items and are no longer distinguishable, leading to the appearance of higher funding (Table 1, Figure 2 ). 
Methods, Sources, and Assumptions
This year's analysis employed similar methods and sources as were used in previous articles in this series. Sources for the FY2014 analysis include agency ''Budgets in Brief,'' agency budget justifications, and personal contact with agency representatives to obtain and track civilian biodefense funding. In order to make this analysis readable, funding amounts for FY2001-FY2005 have been collapsed into 1 column in the tables. Please see previous Federal Biodefense Funding analyses for a full, detailed description of methods, sources, assumptions, and FY2001-FY2005 funding details. [1] [2] [3] [4] [5] [6] [7] [8] [9] In addition to the analysis of biodefense funding by federal agency, this article includes an updated assessment of the proportion of civilian biodefense funding, from FY2001 through FY2014, that has been dedicated to programs with objectives solely related to biodefense versus the amount provided for programs with both biodefense and nonbiodefense goals and applications.
For the purpose of this analysis, a program with objectives solely related to biodefense is defined as a program that focuses entirely on prevention, preparedness, and/or mitigation of deliberate biological threats to civilians. Some specific examples of programs with solely biodefense goals are the DHS BioWatch program for biological agent early detection, HHS smallpox and anthrax vaccine research, and DoD cooperative biological threat reduction programs to engage former bioweapons scientists in new biological research activities.
A program with both biodefense and nonbiodefense goals is defined as a program that serves one or more purposes beyond biodefense. At least 1 major element of the program is specifically related to improving biodefense. However, the program also has objectives related to advancing other areas of science, public health, healthcare, national security, or international security.
Programs with both biodefense and nonbiodefense goals include the HHS Hospital Preparedness Program (HPP), which helps to improve healthcare surge capacity around the country for multiple hazards including bioterrorism; the National Institute of Allergy and Infectious Diseases' (NIAID) Biodefense Research Program, which, in addition to funding preclinical and clinical research toward biodefense countermeasures, also funds basic infectious disease pathogenesis and immunology research with implications for a multitude of other diseases; and the DoD WMD Civil Support Teams, which would be deployed to respond to a range of disasters in the United States, including a biological attack (Table 2, Figure 2 ).
Civilian Biodefense Funding by Federal Agency

Department of Health and Human Services
For FY2014, the HHS budget would be increased to $4.1 billion, a proposed rise of $114.5 million (3%) above current estimated FY2013 funding levels ( Table 3 ). The majority of the HHS biodefense budget would be used for programs with many public health and medical response or preparedness goals. Of the $4.1 billion proposed budget, only $255 million (for project BioShield and the pilot US Postal Service Medical Countermeasure Dispensing program) would be used solely for biodefense in FY2014 ( Table 2 ).
Programs that make up the majority of requested funds for HHS in FY2014 are located in the US Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Office of the Assistant Secretary for Preparedness and Response (ASPR) (Figure 3 CDC Preparedness and Response Capability would be reduced by $1.1 million.
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The FY2014 biodefense budget for ASPR shows an increase of $122 million from estimated FY2013 levels. However, this is because of the addition of a new funding request of $250 million for Project BioShield. There is a significant decrease proposed for the Hospital Preparedness Program (HPP), which would be cut by $122.5 million from estimated FY2013 levels. Proposed funding for this program represents a 46% reduction from original FY2006 funding levels. Other programs in ASPR would be funded at a relatively steady level. The Biomedical Advanced Research and Development Authority (BARDA) would receive $415 million. This funding would not be reallocated from the BioShield Special Reserve Fund as in past years, and it would include $20 million for the proposed Strategic Investor program. 12 In the FDA, the Advancing Medical Countermeasure Initiative would receive an 18% increase to 23.5 million. 13 A separate Medical Countermeasures program would receive an increase of $11.1 million to $111.3 million, and funds would also be provided to operationalize the Life Sciences Biodefense Lab. Food Defense and Physical Security funding would remain flat.
Finally, biodefense research administered through the National Institute of Allergy and Infectious Diseases (NIAID) in NIH would be funded with a $9.9 million increase from estimated FY2013 funding levels. 14 
Department of Defense
The FY2014 DoD budget includes $1.16 billion for its civilian biodefense-related programs and activities, a $27 million increase (2%) over the estimated FY2013 budget amount (Table 4) . 15 16 Examples of programmatic work under CBE includes the support of, construction of, and research in microbiology and public health laboratories overseas and continuing Cooperative Biological Research projects in partner nations. 16 DARPA's Biological Warfare Defense program focuses on developing technologies for pathogen detection, prevention, treatment, and remediation and works jointly with other government agencies to fund programs supporting new approaches to biodefense. This program would receive an increase of $5.3 million over the FY2013 estimate, for a total of $24.5 million. 18 Finally, the Army National Guard is budgeted to receive $182.8 million for their WMD Civil Support Teams (CST), a slight decrease from the FY2013 estimate. 15, 17 This funding supports training and equipment for a range of force configurations of various sizes, capabilities, and deployment time lines that would be deployed in the event of a catastrophic disaster, including bioterrorism, on US soil.
Department of Homeland Security
The DHS budget request for civilian biodefense programs totals $1.05 billion for FY2014 (Table 5) . 19, 20 This is a significant increase over FY2013 funding, estimated at $358.1 million. The proposed increase in funding levels is almost entirely due to funding for construction of the National Bio and Agro-Defense Facility (NBAF). Proposed FY2014 funding for programs in the DHS Office of Health Affairs was reduced to $101.3 million, a 24% reduction from estimated FY2013 funding levels. Funding for the National Biosurveillance Integration Center would be cut by 34% to $8 million, while BioWatch would be reduced by $24.3 million, a 21% reduction. Much of this reduction is related to the defunding of BioWatch Generation 3, for which no funding was requested in the President's FY2014 budget. 21 A new Medical Countermeasures program was added to the analysis this year and is budgeted at $1.9 million. The new program will provide countermeasures to DHS mission-essential personnel in accordance with Executive Order 13527. 19 Several civilian biodefense programs would receive increased or level funding for FY2014 in the DHS Science and Technology Directorate (S&T). These include the Bioagent Detection Program, the Bioagent Threat Assessment Program, the Bioagent Attack Resiliency Program, and operations at the Plum Island Animal Disease Center and the National Biodefense Analysis and Countermeasures Center. Not counting construction funds, proposed changes to biodefense programs in S&T amount to approximately a 7% increase. The large increase in overall 
National Science Foundation
The National Science Foundation's FY2014 budget request includes $15 million for its biodefense-related activities, a funding level on par with recent years (Table 10) . 27 The sole program with a biodefense mission is Microbial Genomics, Analysis and Modeling in the NSF BIO directorate.
Department of Veterans Affairs
For FY2014, the US Department of Veterans Affairs (VA) budgeted $700,000 for its civilian biodefense-related activities, level with the past 2 years (Table 11 ). The sole biodefense program in the VA is the Emerging Pathogens/ Bio-Terrorism line item. This program is new to the analysis this year, and funding since FY2006 has been included. Previous funding information for this program was unavailable. 28 
Conclusion
The President's FY2014 budget requests $6.69 billion for civilian biodefense. This request represents an increase in requested funds over estimated FY2013 levels. The majority of the ''biodefense'' programs included in the FY2014 budget are intended not only to improve biodefense, but also to improve preparedness and response more broadly. Of the FY2014 funds budgeted for civilian biodefense, $5.86 billion (88%) is budgeted for programs with both biodefense and nonbiodefense goals and applications, and $835 million (12%) is budgeted for programs that have objectives solely related to biodefense (Figure 2) .
HHS would receive the largest proportion of biodefense funding (61%), followed by DoD (17%), DHS (16%), Commerce (2%), EPA (2%), USDA (1%), State (1%), NSF (<1%), and VA (<1%). Many of these agencies would receive increased funding above estimated FY2013 levels. The largest increase in funding would go to DHS, while smaller increases would be provided for DoD, HHS, Commerce, and USDA. The State Department and the EPA would receive decreases in biodefense funding, while the NSF and VA would maintain flat funding (Figure 3) .
It should be noted that estimated levels from FY2013 are uncertain due to Continuing Resolutions and the
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Sequestration process. Although the analysis shows an increase in proposed FY2014 levels of funding compared to estimated FY2013 levels, there is still significant uncertainty about appropriations totals for FY2013.
